aim bisphosphonaterelated osteonecrosis of the jaw bronj is a serious oral complication of supportive cancer therapy and the best method of treatment is still unclearthe purpose of this article is to analyze the type of treatment and outcome in a large patient cohort with bronjpatients and methods a total of 142 patients suffering from bronj at different sites were studiedall patients had been treated with intravenous bisphosphonates for various oncological diseasea descriptive analysis of all relevant patient data was performed with particular emphasis on surgical outcomeresults the mandible was affected in 58 of the patientsall but two patients had previous invasive dental proceduresthe mean duration of bisphosphonate treatment was 371 monthsa total of 86 of the patients were treated surgically including sequestrectomies and mandibular resectionssofttissue reconstruction was achieved by local closure myofascial flap using the mylohyoid muscle and a vascularized fasciocutaneous flap in one patientno bony reconstruction was performedconclusion surgical treatment of bronj remains challengingthere is only limited evidence that oncologic patients with bronj are candidates for vascularized bone reconstruction